Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Cory Hogaboam

Cory Hogaboam

individual
Ecosystem influencer

About

Cory M. Hogaboam, PhD, is a pulmonary-disease researcher focused on fibrosis, immunology, and idiopathic pulmonary fibrosis. He is a Professor of Medicine and research scientist in the Women's Guild Lung Institute at Cedars-Sinai, an adjunct professor of pathology at the University of Michigan Medical School, and serves as Chief Scientific Officer of Rein Therapeutics. He also holds scientific advisory roles with biotech companies including Rubedo Life Sciences and Lassen Therapeutics.

Areas of interest

biotechpulmonary diseaseidiopathic pulmonary fibrosisfibrosisimmunologylung biologydrug developmenttranslational medicineaginglongevity